Item 5. Other Information
Item 5. Other Information.
None.
Item 6. Exhibits
The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth on the Exhibit Index, which Exhibit Index is incorporated herein by reference.
43
EXHIBIT INDEX
Exhibit No. Description
4.1 Form of Warrant (filed with the SEC as Exhibit 4.1 to the Company's Form 8-K filed on September 25, 2020)
4.2 Form of Pre-Funded Warrant (filed with the SEC as Exhibit 4.2 to the Company's Form 8-K filed on September 25, 2020)
10.1# Russell Skibsted Employment Agreement, dated September 15, 2020 (filed with the SEC as Exhibit 10.1 to the Company’s Form 8-K filed on September 16, 2020)
10.2# Securities Purchase Agreement dated September 23, 2020 (filed with the SEC as Exhibit 10.1 to the Company’s Form 8-K filed on September 25, 2020)
31.1* Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
31.2* Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
32.1#** Certification pursuant to 18 U.S.C. Section 1350 and Rule 13a-14(b) of the Securities Exchange Act of 1934
101.INS* XBRL Instance Document
101.SCH* XBRL Taxonomy Extension Schema
101.CAL* XBRL Taxonomy Extension Calculation Linkbase
101.DEF* XBRL Taxonomy Extension Definition Database
101.LAB* XBRL Taxonomy Extension Label Linkbase
101.PRE* XBRL Taxonomy Extension Presentation Linkbase
104* The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, formatted in Inline XBRL (included as Exhibit 101)
* Filed herewith
#** Furnished herewith and not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act
# Indicates management contracts or compensatory plans or arrangements.
44
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ROCKWELL MEDICAL, INC.
(Registrant)
Date: November 9, 2020 /s/ Russell Ellison
Russell Ellison
Chief Executive Officer (Principal Executive Officer)
Date: November 9, 2020 /s/ Russell Skibsted
Russell Skibsted
Chief Financial Officer (Principal Financial Officer)
45
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.